ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Book For Survivors, Other New Publications

August 23, 1991

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975